1-4 of 4
Holly M. Gundacker
Close
Sort by
Journal Articles

Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).

Harry P. Erba, MD, PhD, Kenneth J. Kopecky, PhD, Mark H. Kirschbaum, MD, Martin S. Tallman, MD, Richard A. Larson, MD, Cheryl L. Willman, MD, Marilyn L. Slovak, PhD, Holly M. Gundacker, MA, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2007) 110 (11): 440.
https://doi.org/10.1182/blood.V110.11.440.440
Published: 2007
Journal Articles

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Clinical Trials & Observations Brief Report
Olga Sala-Torra, Holly M. Gundacker, Derek L. Stirewalt, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, Cheryl L. Willman, Shelly Heimfeld, David H. Boldt, Jerald P. Radich
Journal: Blood
Blood (2006) 109 (7): 3080–3083.
https://doi.org/10.1182/blood-2006-06-031096
Published: 2006
Journal Articles

Changes in the Pattern of Cytogenetic Aberrations with Advancing Age in Acute Myeloid (Non-APL) Leukemia: A Southwest Oncology Study (S9007).

Thomas H. Norwood, MD, Holly M. Gundacker, MS, Marilyn L. Slovak, PhD, Harry Paul Erba, MD, PhD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2006) 108 (11): 808.
https://doi.org/10.1182/blood.V108.11.808.808
Published: 2006
Journal Articles

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Olga Sala-Torra, MD, Holly M. Gundacker, Derek L. Stirewalt, MD, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, PhD, Cheryl L. Willman, MD, Shelly Heimfeld, PhD, David H. Boldt, MD, Jerald P. Radich, MD
Journal: Blood
Blood (2005) 106 (11): 336.
https://doi.org/10.1182/blood.V106.11.336.336
Published: 2005